SHJBF OTC
Shanghai Junshi Biosciences Co., Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +8.8%
1Y: -14.8%
3Y: -40.2%
$3.35
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$466M
+67.7% ▲
Capital Expenditures
$748M
-8.3% ▼
5Y CAGR: +4.8%
Free Cash Flow
-$1.2B
+43.1% ▲
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$221M
+117.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$593M | -$2.7B | -$2.3B | -$1.4B | -$853M |
| Depreciation & Amort. | $263M | $294M | $303M | $284M | $310M |
| Stock-Based Comp. | $193M | $92M | $23M | $0 | $0 |
| Change in Working Capital | -$319M | $687M | -$81M | -$474M | -$4M |
| Other Non-Cash Items | -$176M | -$152M | $23M | $106M | $82M |
| Operating Cash Flow | -$642M | -$1.8B | -$2.0B | -$1.4B | -$466M |
| — Investing Activities — | |||||
| Capital Expenditures | -$886M | -$394M | -$833M | -$684M | -$748M |
| Acquisitions (Net) | -$440M | -$94M | -$19M | $346M | -$7M |
| Investment Purchases | -$1.2B | -$8M | -$1.4B | -$2.1B | -$3.0B |
| Investment Sales | $565M | $14M | $1.2B | $1.5B | $2.2B |
| Other Investing | $50M | $15M | $148M | $55M | $801K |
| Investing Cash Flow | -$1.9B | -$468M | -$892M | -$877M | -$1.6B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$293M | $727M | $496M | $1.1B | $1.2B |
| Stock Repurchased | $0 | $0 | -$27M | -$4M | $0 |
| Dividends Paid | -$17M | -$19M | -$38M | -$74M | $0 |
| Other Financing | $826M | $123M | $97M | -$38M | $1.0B |
| Financing Cash Flow | $2.7B | $4.6B | $681M | $1.0B | $2.2B |
| Net Change in Cash | $120M | $2.5B | -$2.2B | -$1.3B | $221M |
| Cash End of Period | $3.5B | $6.0B | $3.8B | $2.5B | $2.6B |
| Free Cash Flow | -$1.5B | -$2.2B | -$2.8B | -$2.1B | -$1.2B |